Harvard Bioscience (HBIO) Q4 2024 Annual Earnings
HBIO·Reported March 12, 2025·Before market open
Harvard Bioscience reported Q4 2024 revenue of $24.6M, beat analyst consensus of $21.0M by $3.6M. Diluted EPS came in at $0.06, beat the $0.05 consensus by $0.01.
Revenue
$24.6Mbeat by $3.6M
Consensus: $21.0MDiluted EPS
$0.06beat by $0.01
Consensus: $0.05
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Harvard Bioscience's Q4 2024 earnings report.
Harvard Bioscience (HBIO) reported Q4 2024 earnings on March 12, 2025 before market open.
Harvard Bioscience reported revenue of $24.6M and diluted EPS of $0.06 for Q4 2024.
Revenue beat the consensus estimate of $21.0M by $3.6M. EPS beat the consensus estimate of $0.05 by $0.01.
You can read the 10-K periodic report (0001171843-25-001472) directly on SEC EDGAR. The filing index links above go to sec.gov.